NeoStem Inc.

NeoStem, Inc. ("NeoStem" or the "Company") an international biopharmaceutical company with product and service revenues, global research and develop...

NeoStem, Inc. ("NeoStem" or the "Company") an international biopharmaceutical company with product and service revenues, global research and develop...

NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today that it...

NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today that it...

NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that Dr...

NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that Dr...

NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that it...

NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that it...

Goldman Small Cap Research, which produces free, timely, actionable, research on publicly-traded emerging growth companies has initiated coverage on NeoStem with a recom...

Adult stem cell leader Neostem, Inc. has been awarded a $700,000 military grant from the U.S. Army's Medical Research and Materiel Command to study adult stem cell appli...